Park Medi World

Park Medi World delivered its strongest year ever in FY26, with revenue of ₹1,679 CrCurrent reported value: ₹1,679 Cr. No comparable prior figure is available in the source record. (+21Current reported value: 21. No comparable prior figure is available in the source record.% YoY), EBITDA of ₹444 CrCurrent reported value: ₹444 Cr. No comparable prior figure is available in the source record. (+20% YoY), and PAT of ₹274 CrCurrent reported value: ₹274 Cr. No comparable prior figure is available in the source record. (+27Current reported value: 27. No comparable prior figure is available in the source record.% YoY). Q4 revenue grew 30% YoYCurrent reported value: 30% YoY. No comparable prior figure is available in the source record. to ₹460Current reported value: 460. No comparable prior figure is available in the source record. Cr, with EBITDA margin expanding 268 bps to 28Current reported value: 28. No comparable prior figure is available in the source record.%. The stellar performance was driven by record patient volumes (IPD +18% YoY to 95,525Current 95,525. Reported change: +18% YoY., OPD +22% YoY to 7.78 lakh), occupancy improvement to 64.1%Current 64.1%. Reported change: +244 bps YoY. (+244 bps), and a deliberate shift toward high-end specialties (56.9%Current 56.9%. Reported change: +316 bps YoY. of revenue, +316 bps). The company added 610 beds during the year, taking total capacity to 3,610Current 3,610. Reported change: +610 beds YoY. beds, and plans to reach 5,460 beds by March 2028 with a capex of ~₹500 Cr over two years. Management guided for a CGHS rate hike benefit of 5-6% to revenue in FY27 and expects margins to remain range-bound. Key risk: receivable days at 129 remain elevated due to government payment cycles, though improving.